pargyline has been researched along with Hyperlipemia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selchau, M | 1 |
1 review available for pargyline and Hyperlipemia
| Article | Year |
|---|---|
[Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders].
Topics: Acetylcholine; Adenosine Triphosphate; Amines; Angiotensin II; Anticholesteremic Agents; Antihyperte | 1970 |